Cargando…

Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer

BACKGROUND: Fibrinogen-like protein 2 (FGL2) is a member of the fibrinogen-like protein family and possesses important regulatory functions in both innate and adaptive immune responses. FGL2 is overexpressed in glioma, and its expression level is negatively associated with the prognosis of glioma pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yanyan, Guo, Chunguang, Wang, Hesong, Zhao, Lu, Wang, Wei, Wang, Ting, Feng, Yuyin, Yuan, Kai, Huang, Guangrui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Database Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409386/ https://www.ncbi.nlm.nih.gov/pubmed/32716910 http://dx.doi.org/10.12659/MSM.923531

Ejemplares similares

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
por: Qian, Wenjing, et al.
Publicado: (2021)

Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer
por: Yi, Weiwei, et al.
Publicado: (2021)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
por: Li, Zongkuo, et al.
Publicado: (2022)

Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients
por: Liu, Xinyu, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Reveals Potential Pathway Biomarkers and Their Interactions for Clubfoot
por: Ding, Jing, et al.
Publicado: (2020)

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma
por: Zhao, Xuemiao, et al.
Publicado: (2021)

Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics Analysis
por: Wang, Xin, et al.
Publicado: (2020)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
por: Luo, Min, et al.
Publicado: (2021)

Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer
por: Gao, Chanchan, et al.
Publicado: (2021)

Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis
por: Li, Dong, et al.
Publicado: (2021)

Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8(+)regulatory T cells-mediated long-term graft survival
por: Bézie, Séverine, et al.
Publicado: (2011)

Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis
por: Zhao, Min, et al.
Publicado: (2020)

Bioinformatics Analysis and Identification of Underlying Biomarkers Potentially Linking Allergic Rhinitis and Asthma
por: Yan, Zhanfeng, et al.
Publicado: (2020)

Early Death Incidence and Prediction in Stage IV Breast Cancer
por: Zhao, Yumei, et al.
Publicado: (2020)

Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer
por: Shan, Zexing, et al.
Publicado: (2021)

Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer
por: Lu, Xunxi, et al.
Publicado: (2020)

Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020)

The Mechanisms of Sijunzi Decoction in the Treatment of Chronic Gastritis Revealed by Network Pharmacology
por: Wang, Ting, et al.
Publicado: (2020)

Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data
por: Zhang, Xinxin, et al.
Publicado: (2020)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
por: Hu, Chuan, et al.
Publicado: (2020)

Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer
por: Cheng, Lin, et al.
Publicado: (2020)

Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study
por: Li, Yu-feng, et al.
Publicado: (2020)

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021)

High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma
por: Zhou, Zhaoping, et al.
Publicado: (2020)

Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy
por: Hou, Rongrong, et al.
Publicado: (2023)

Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes
por: Du, Xiaomei, et al.
Publicado: (2020)

Bioinformatics Analysis of Differentially Expressed Genes and Protein–Protein Interaction Networks Associated with Functional Pathways in Ulcerative Colitis
por: Cao, Feng, et al.
Publicado: (2021)

Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer
por: Zhu, Jin, et al.
Publicado: (2020)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study
por: Zhang, Biyu, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma
por: Zhang, Dehua, et al.
Publicado: (2020)

An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
por: Yang, Zhi-Qiang, et al.
Publicado: (2020)

Combining Blood-Based Biomarkers to Predict Mortality of Sepsis at Arrival at the Emergency Department
por: Xie, Yinjing, et al.
Publicado: (2021)

Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer
por: Zhang, Zhiyong, et al.
Publicado: (2021)

TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
por: Zhou, Fang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sj0h5mvljfp4o5f162iacaqd40